GBIO

Generation Bio Co

Jan 27 • 04:00PM ET

5.67

-0.01 -0.18 %

Healthcare • Biotechnology • USA • NASD

Peers: NTLA CRSP EDIT BEAM SGMO SRPT BLUE PSTX IOVA ADVM

Index	-	P/E	-	EPS (ttm)	-9.35	Insider Own	37.09%	Shs Outstand	6.74M	Perf Week	1.43%
Market Cap	38.20M	Forward P/E	-	EPS next Y	-2.55	Insider Trans	0.00%	Shs Float	4.24M	Perf Month	1.98%
Enterprise Value	-25.32M	PEG	-	EPS next Q	-5.50	Inst Own	42.24%	Short Float	0.05%	Perf Quarter	-7.05%
Income	-62.63M	P/S	2.50	EPS this Y	51.63%	Inst Trans	-4.48%	Short Ratio	0.03	Perf Half Y	20.64%
Sales	15.27M	P/B	0.76	EPS next Y	73.32%	ROA	-33.79%	Short Interest	0.00M	Perf YTD	-0.18%
Book/sh	7.51	P/C	0.43	EPS next 5Y	68.77%	ROE	-80.81%	52W High	9.25 -38.72%	Perf Year	-39.52%
Cash/sh	13.30	P/FCF	-	EPS past 3/5Y	2.26% -8.29%	ROIC	-89.08%	52W Low	3.00 88.75%	Perf 3Y	-87.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	68.24%	Volatility	2.47% 2.83%	Perf 5Y	-98.23%
Dividend TTM	-	EV/Sales	-1.66	EPS Y/Y TTM	57.32%	Oper. Margin	-512.53%	ATR (14)	0.16	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.44	Sales Y/Y TTM	-17.82%	Profit Margin	-410.13%	RSI (14)	56.69	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.44	EPS Q/Q	64.28%	SMA20	1.67%	Beta	2.05	Target Price	6.83
Payout	-	Debt/Eq	0.52	Sales Q/Q	-78.90%	SMA50	4.35%	Rel Volume	1.00	Prev Close	5.68
Employees	115	LT Debt/Eq	0.39	Earnings	Nov 05 AMC	SMA200	13.32%	Avg Volume	77.73K	Price	5.67
IPO	Jun 12, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	73.97% 141.52%	Trades		Volume	77,080	Change	-0.18%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-16-25	Upgrade	Wedbush	Neutral → Outperform	$5.50
Dec-16-25	Downgrade	Jefferies	Buy → Hold	$5
Aug-13-25	Downgrade	Wedbush	Outperform → Neutral	$7
Oct-19-23	Downgrade	TD Cowen	Outperform → Market Perform
Nov-08-22	Initiated	Canaccord Genuity	Buy	$9
Dec-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Jun-08-21	Initiated	JMP Securities	Mkt Outperform	$40
Feb-24-21	Initiated	William Blair	Outperform
Feb-18-21	Initiated	Needham	Buy	$50
Jul-07-20	Initiated	Wedbush	Outperform	$31
Jul-07-20	Initiated	JP Morgan	Overweight	$28
Jul-07-20	Initiated	Jefferies	Buy	$38
Jul-07-20	Initiated	Cowen	Outperform

Show Previous Ratings

Jan-23-26 11:01AM	Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Jan-13-26 01:52AM	Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Dec-16-25 11:21AM	Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
03:03AM	Zombie biotech buyer Xoma to acquire Generation Bio (BioPharma Dive)
Dec-15-25 05:00PM	XOMA Royalty Enters into Agreement to Acquire Generation Bio (GlobeNewswire)
04:05PM	Loading…
Nov-05-25 04:05PM	Generation Bio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 06:30AM	Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors (Business Wire)
Oct-22-25 04:05PM	Generation Bio Announces CEO Transition (GlobeNewswire)
Aug-15-25 07:20AM	Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial (BioPharma Dive) -5.56%
Aug-12-25 05:30PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +63.21%
04:05PM	Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results (GlobeNewswire)
03:00PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-18-25 08:35AM	Generation Bio Announces 1-for-10 Reverse Stock Split (GlobeNewswire) -22.08%
Jul-07-25 04:05PM	Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.94%
May-28-25 06:59AM	Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
05:35PM	Loading…
May-07-25 05:35PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.77%
04:05PM	Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results (GlobeNewswire)
Apr-02-25 06:59AM	Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference (GlobeNewswire)
Mar-13-25 05:15PM	Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.25%
04:05PM	Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-24-25 06:59AM	Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Jan-06-25 04:30PM	Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases (GlobeNewswire) -8.77%
Nov-06-24 05:40PM	Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +9.59%
04:05PM	Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-22-24 06:59AM	Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress (GlobeNewswire)
Sep-12-24 04:05PM	Generation Bio to Present at the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-07-24 11:54PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -9.39% +8.11%
07:35PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Generation Bio Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-06-24 06:59AM	Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire) +7.46%
06:59AM	Loading…
Jun-14-24 06:59AM	Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit (GlobeNewswire) -19.88%
Jun-03-24 04:30PM	Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-13-24 09:54PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -5.02% +24.65%
05:15PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 06:59AM	Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting (GlobeNewswire) +5.16%
May-04-24 10:49AM	Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-22-24 05:31PM	Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting (GlobeNewswire) +16.01%
Apr-02-24 06:59AM	Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-08-24 04:32AM	Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes (GuruFocus.com) +18.98%
Mar-06-24 10:52PM	GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) +6.50%
05:40PM	Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-27-24 06:59AM	Generation Bio to Present at the 2024 TD Cowen Health Care Conference (GlobeNewswire) +6.79%
Jan-03-24 04:05PM	Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-06-23 03:05AM	Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO) (GuruFocus.com) +24.81%
Nov-29-23 08:41AM	Generation Bio eliminates 40% of staff, including 2 C-suite execs, in pivot to ex-liver targets (FierceBiotech.com)
06:59AM	Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms (GlobeNewswire)
Nov-09-23 04:15PM	Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results (GlobeNewswire) -11.11% +10.58%
Oct-26-23 06:59AM	Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform (GlobeNewswire)
Oct-18-23 06:59AM	Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel Immune-Quiet DNA (GlobeNewswire) -22.51%
Sep-19-23 07:30AM	Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit (GlobeNewswire)
Aug-03-23 08:49AM	Insider Buyers Lose US$80k As Generation Bio Sheds US$37m (Simply Wall St.)
07:30AM	Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Aug-02-23 07:05PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.49%
04:15PM	Generation Bio Reports Second Quarter 2023 Financial Results (GlobeNewswire)
May-31-23 07:30AM	Generation Bio to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire) -7.41%
May-10-23 06:05PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -7.29%
04:15PM	Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results (GlobeNewswire)
May-09-23 04:15PM	Generation Bio to Present at the JMP Securities Life Sciences Conference (GlobeNewswire)
Apr-11-23 07:30AM	Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +7.21%
Apr-10-23 09:40AM	Here's Why We're Not At All Concerned With Generation Bio's (NASDAQ:GBIO) Cash Burn Situation (Simply Wall St.)
Apr-05-23 07:30AM	Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer (GlobeNewswire)
Mar-24-23 03:02PM	Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio (Zacks)
Mar-23-23 10:43AM	Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines (Benzinga) +28.87%
07:29AM	UPDATE 2-Moderna signs licensing deal with Generation Bio in push beyond COVID (Reuters)
07:00AM	Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines (GlobeNewswire)
Mar-21-23 04:15PM	Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines (GlobeNewswire)
Feb-27-23 07:30AM	Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
Feb-24-23 07:18AM	Bullish insiders bet US$536k on Generation Bio Co. (NASDAQ:GBIO) (Simply Wall St.) -9.44%
Feb-23-23 04:28PM	Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Jan-03-23 04:30PM	Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +26.68%
Dec-05-22 09:55AM	Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect? (Zacks) -12.85%
Nov-17-22 09:55AM	Wall Street Analysts Think Generation Bio Co. (GBIO) Could Surge 176%: Read This Before Placing a Bet (Zacks)
Nov-03-22 04:15PM	Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results (GlobeNewswire) +12.88%
Nov-01-22 08:07AM	We're Hopeful That Generation Bio (NASDAQ:GBIO) Will Use Its Cash Wisely (Simply Wall St.) +9.57%
Sep-22-22 07:30AM	Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit (GlobeNewswire)
Sep-20-22 07:30AM	Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer (GlobeNewswire)
Sep-17-22 08:12AM	A number of insiders bought Generation Bio Co. (NASDAQ:GBIO) stock last year, which is great news for shareholders (Simply Wall St.)
Aug-04-22 05:45PM	Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +7.33%
04:15PM	Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 04:15PM	Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference (GlobeNewswire) +17.55%
Jul-18-22 07:30AM	Generation Bio Appoints Dannielle Appelhans to Its Board of Directors (GlobeNewswire) -5.99%
Jul-11-22 09:55AM	Wall Street Analysts See a 174% Upside in Generation Bio Co. (GBIO): Can the Stock Really Move This High? (Zacks) -8.54%
Jun-21-22 08:30AM	Generation Bio Announces Update to Its GMP Manufacturing Strategy (GlobeNewswire) +10.02%
Jun-02-22 07:30AM	Generation Bio to Present at the 2022 Jefferies Healthcare Conference (GlobeNewswire)
May-25-22 06:37AM	Here's Why We're Not Too Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn Situation (Simply Wall St.)
May-05-22 07:05PM	Generation Bio Co. (GBIO) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -9.17% -11.65%
04:15PM	Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results (GlobeNewswire)
Apr-05-22 07:30AM	Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-25-22 12:00PM	Generation Bio Co. (GBIO) Upgraded to Buy: Here's Why (Zacks)
10:00AM	How Much Upside is Left in Generation Bio Co. (GBIO)? Wall Street Analysts Think 505% (Zacks)
Mar-02-22 07:30AM	Generation Bio to Participate in 42nd Annual Cowen Health Care Conference (GlobeNewswire)
Feb-24-22 04:20PM	Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) +9.09% +10.96%
Feb-10-22 07:30AM	Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer (GlobeNewswire) -11.51%
Jan-05-22 07:30AM	Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.52%
Dec-28-21 07:37PM	SHAREHOLDER ALERT: Robbins LLP Investigates Generation Bio Co. (GBIO) on Behalf of Shareholders (Business Wire) -8.40%
Dec-19-21 09:37PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO (GlobeNewswire)

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GBIO

Generation Bio Co

Upgrade your FINVIZ experience